SLC7A11 and peripheral arterial disease: While STAT3 was previously reported to both inhibit and promote ferroptosis, our findings suggest that any protective effects of STAT3-mediated GPX4 and SLC7A11 upregulation are insufficient to prevent ferroptosis in PAD muscle tissue [55,56].